Academic Journal

Plasmacytoid dendritic cells initiate a complex chemokine and cytokine network and are a viable drug target in chronic HCV patients

التفاصيل البيبلوغرافية
العنوان: Plasmacytoid dendritic cells initiate a complex chemokine and cytokine network and are a viable drug target in chronic HCV patients
المؤلفون: Decalf, Jérémie, Fernandes, Sandrine, Longman, Randy, Ahloulay, Mina, Audat, François, Lefrerre, François, Rice, Charles M., Pol, Stanislas, Albert, Matthew L.
المساهمون: Immunobiologie des Cellules Dendritiques, Institut Pasteur Paris (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM), Carcinogenèse Hépatique et Virologie Moléculaire, Institut National de la Santé et de la Recherche Médicale (INSERM), Rockefeller University New York, Hôpital Necker - Enfants Malades AP-HP, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), This work was supported in part by grants from La Ligue Nationale Contre le Cancer (J. Decalf and M.L. Albert), L'Agence Nationale de Recherches sur le SIDA et Hépatites, The European Young Investigator Awards Scheme, European Science Foundation, The Doris Duke Charitable Foundation, the Greenberg Medical Research Institute (C.M. Rice), and special support from Le Caisse de Retraite et de Prévoyance des Clercs et Employés de Notaires (M.L. Albert).
المصدر: ISSN: 0022-1007.
بيانات النشر: HAL CCSD
Rockefeller University Press
سنة النشر: 2007
المجموعة: Institut Pasteur: HAL
مصطلحات موضوعية: [SDV.IMM]Life Sciences [q-bio]/Immunology
الوصف: International audience ; Plasmacytoid dendritic cells (pDCs) are the professional type I interferon (IFN)-producing cells, and upon activation they traffic to lymph organs, where they bridge innate and adaptive immunity. Using multianalyte profiling (MAP), we have mapped the key chemokines and cytokines produced in response to pDC activation, taking into consideration the role of autocrine IFN, as well as paracrine effects on other innate cells (e.g., monocytes and conventional DCs). Interestingly, we identify four distinct cytokine/chemokine loops initiated by Toll-like receptor engagement. Finally, we applied this analytic approach to the study of pDC activity in chronic hepatitis C patients. Based on the activation state of pDCs in fresh blood, the lack of agonistic activity of infectious virions, the production of a broad array of cytokines/chemokines once stimulated, and the direct effects of pDCs on other PBMCs, we conclude that the pDCs from hepatitis C virus (HCV)-infected individuals are fully functional and are, indeed, a viable drug target. In sum, this study provides insight into the use of MAP technology for characterizing cytokine networks, and highlights how a rare cell type integrates the activation of other inflammatory cells. Furthermore, this work will help evaluate the therapeutic application of pDC agonists in diseases such as chronic HCV infection.
نوع الوثيقة: article in journal/newspaper
اللغة: English
Relation: info:eu-repo/semantics/altIdentifier/pmid/17893202; pasteur-01402312; https://pasteur.hal.science/pasteur-01402312; https://pasteur.hal.science/pasteur-01402312/document; https://pasteur.hal.science/pasteur-01402312/file/2423-full.pdf; PUBMED: 17893202; PUBMEDCENTRAL: PMC2118448
DOI: 10.1084/jem.20070814
الاتاحة: https://pasteur.hal.science/pasteur-01402312
https://pasteur.hal.science/pasteur-01402312/document
https://pasteur.hal.science/pasteur-01402312/file/2423-full.pdf
https://doi.org/10.1084/jem.20070814
Rights: info:eu-repo/semantics/OpenAccess
رقم الانضمام: edsbas.224C5B81
قاعدة البيانات: BASE